
|Articles|November 28, 2007
Marketed AMD therapies
Take a look at the therapies that have already reached the market.
Advertisement
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times Europe
1
Macular laser picks up speed: The technology accelerating retinal therapies
2
FLORetina 2025: Remotely managing patients with neovascular age-related macular degeneration
3
FLORetina 2025: Antithrombotic use examined in wet AMD submacular hemorrhage
4
FLORetina 2025: EU-ROP Registry bridges borders for real-world insight
5













































